nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNC3—cerebellar cortex—malignant glioma	0.0465	0.0681	CbGeAlD
Dalfampridine—KCNH1—embryo—malignant glioma	0.00953	0.014	CbGeAlD
Dalfampridine—KCNA6—telencephalon—malignant glioma	0.00911	0.0134	CbGeAlD
Dalfampridine—KCNV2—retina—malignant glioma	0.00883	0.0129	CbGeAlD
Dalfampridine—KCNV1—telencephalon—malignant glioma	0.00857	0.0126	CbGeAlD
Dalfampridine—KCNC2—telencephalon—malignant glioma	0.00775	0.0114	CbGeAlD
Dalfampridine—KCNC3—brainstem—malignant glioma	0.00731	0.0107	CbGeAlD
Dalfampridine—KCND1—embryo—malignant glioma	0.00706	0.0104	CbGeAlD
Dalfampridine—KCNH3—telencephalon—malignant glioma	0.0069	0.0101	CbGeAlD
Dalfampridine—KCNA2—brainstem—malignant glioma	0.00677	0.00992	CbGeAlD
Dalfampridine—KCNB1—telencephalon—malignant glioma	0.00669	0.0098	CbGeAlD
Dalfampridine—KCNG2—cerebellum—malignant glioma	0.00668	0.00979	CbGeAlD
Dalfampridine—KCND1—brainstem—malignant glioma	0.00647	0.00949	CbGeAlD
Dalfampridine—KCNA4—telencephalon—malignant glioma	0.00631	0.00926	CbGeAlD
Dalfampridine—KCNA3—telencephalon—malignant glioma	0.00631	0.00926	CbGeAlD
Dalfampridine—KCNC1—brainstem—malignant glioma	0.00622	0.00912	CbGeAlD
Dalfampridine—KCNG4—central nervous system—malignant glioma	0.00609	0.00893	CbGeAlD
Dalfampridine—KCNH4—central nervous system—malignant glioma	0.00609	0.00893	CbGeAlD
Dalfampridine—KCNB2—central nervous system—malignant glioma	0.00609	0.00893	CbGeAlD
Dalfampridine—KCNA2—telencephalon—malignant glioma	0.00601	0.0088	CbGeAlD
Dalfampridine—KCNS1—telencephalon—malignant glioma	0.00601	0.0088	CbGeAlD
Dalfampridine—KCNQ4—retina—malignant glioma	0.006	0.0088	CbGeAlD
Dalfampridine—KCNQ5—retina—malignant glioma	0.00584	0.00856	CbGeAlD
Dalfampridine—KCNC4—telencephalon—malignant glioma	0.00575	0.00842	CbGeAlD
Dalfampridine—KCNH5—central nervous system—malignant glioma	0.00557	0.00816	CbGeAlD
Dalfampridine—KCNC1—telencephalon—malignant glioma	0.00552	0.00809	CbGeAlD
Dalfampridine—KCNH3—medulla oblongata—malignant glioma	0.00542	0.00795	CbGeAlD
Dalfampridine—KCNG2—brain—malignant glioma	0.00542	0.00795	CbGeAlD
Dalfampridine—KCNH8—medulla oblongata—malignant glioma	0.00525	0.0077	CbGeAlD
Dalfampridine—KCNA6—central nervous system—malignant glioma	0.00518	0.00759	CbGeAlD
Dalfampridine—KCNS2—central nervous system—malignant glioma	0.00518	0.00759	CbGeAlD
Dalfampridine—KCNA4—medulla oblongata—malignant glioma	0.00496	0.00727	CbGeAlD
Dalfampridine—KCNF1—telencephalon—malignant glioma	0.00492	0.00721	CbGeAlD
Dalfampridine—KCNV1—central nervous system—malignant glioma	0.00487	0.00714	CbGeAlD
Dalfampridine—KCNH3—spinal cord—malignant glioma	0.00484	0.00709	CbGeAlD
Dalfampridine—KCNB2—brain—malignant glioma	0.00483	0.00709	CbGeAlD
Dalfampridine—KCNG4—brain—malignant glioma	0.00483	0.00709	CbGeAlD
Dalfampridine—KCNH4—brain—malignant glioma	0.00483	0.00709	CbGeAlD
Dalfampridine—KCNH8—midbrain—malignant glioma	0.0048	0.00704	CbGeAlD
Dalfampridine—KCNA5—retina—malignant glioma	0.00478	0.00701	CbGeAlD
Dalfampridine—KCNS1—medulla oblongata—malignant glioma	0.00472	0.00692	CbGeAlD
Dalfampridine—KCNH8—spinal cord—malignant glioma	0.00469	0.00687	CbGeAlD
Dalfampridine—KCNV2—central nervous system—malignant glioma	0.00462	0.00677	CbGeAlD
Dalfampridine—KCNA4—midbrain—malignant glioma	0.00453	0.00665	CbGeAlD
Dalfampridine—KCNC4—medulla oblongata—malignant glioma	0.00451	0.00662	CbGeAlD
Dalfampridine—KCNQ2—brainstem—malignant glioma	0.00447	0.00655	CbGeAlD
Dalfampridine—KCNA3—spinal cord—malignant glioma	0.00442	0.00649	CbGeAlD
Dalfampridine—KCNH5—brain—malignant glioma	0.00442	0.00648	CbGeAlD
Dalfampridine—KCNG3—central nervous system—malignant glioma	0.0044	0.00645	CbGeAlD
Dalfampridine—KCNC2—central nervous system—malignant glioma	0.0044	0.00645	CbGeAlD
Dalfampridine—KCNH1—central nervous system—malignant glioma	0.0044	0.00645	CbGeAlD
Dalfampridine—KCNA5—telencephalon—malignant glioma	0.0044	0.00645	CbGeAlD
Dalfampridine—KCNC1—medulla oblongata—malignant glioma	0.00434	0.00636	CbGeAlD
Dalfampridine—KCNS1—midbrain—malignant glioma	0.00431	0.00632	CbGeAlD
Dalfampridine—KCNA2—midbrain—malignant glioma	0.00431	0.00632	CbGeAlD
Dalfampridine—KCNQ3—telencephalon—malignant glioma	0.00431	0.00632	CbGeAlD
Dalfampridine—KCNH1—cerebellum—malignant glioma	0.0043	0.00631	CbGeAlD
Dalfampridine—KCND2—brainstem—malignant glioma	0.00423	0.0062	CbGeAlD
Dalfampridine—KCNA2—spinal cord—malignant glioma	0.00421	0.00617	CbGeAlD
Dalfampridine—KCNC4—midbrain—malignant glioma	0.00413	0.00605	CbGeAlD
Dalfampridine—KCNS2—brain—malignant glioma	0.00411	0.00603	CbGeAlD
Dalfampridine—KCNA6—brain—malignant glioma	0.00411	0.00603	CbGeAlD
Dalfampridine—KCNQ2—telencephalon—malignant glioma	0.00397	0.00581	CbGeAlD
Dalfampridine—KCNC1—midbrain—malignant glioma	0.00396	0.00581	CbGeAlD
Dalfampridine—KCNH6—telencephalon—malignant glioma	0.00393	0.00577	CbGeAlD
Dalfampridine—KCNG1—central nervous system—malignant glioma	0.00392	0.00575	CbGeAlD
Dalfampridine—KCNH3—central nervous system—malignant glioma	0.00392	0.00575	CbGeAlD
Dalfampridine—KCNC1—spinal cord—malignant glioma	0.00387	0.00567	CbGeAlD
Dalfampridine—KCNF1—medulla oblongata—malignant glioma	0.00387	0.00567	CbGeAlD
Dalfampridine—KCNV1—brain—malignant glioma	0.00387	0.00567	CbGeAlD
Dalfampridine—KCNQ5—midbrain—malignant glioma	0.00386	0.00565	CbGeAlD
Dalfampridine—KCNG1—cerebellum—malignant glioma	0.00384	0.00562	CbGeAlD
Dalfampridine—KCNH3—cerebellum—malignant glioma	0.00384	0.00562	CbGeAlD
Dalfampridine—KCNH8—central nervous system—malignant glioma	0.0038	0.00557	CbGeAlD
Dalfampridine—KCNB1—central nervous system—malignant glioma	0.0038	0.00557	CbGeAlD
Dalfampridine—KCND2—telencephalon—malignant glioma	0.00376	0.0055	CbGeAlD
Dalfampridine—KCNH8—cerebellum—malignant glioma	0.00371	0.00545	CbGeAlD
Dalfampridine—KCNA1—brainstem—malignant glioma	0.00371	0.00544	CbGeAlD
Dalfampridine—KCNC3—central nervous system—malignant glioma	0.00369	0.00541	CbGeAlD
Dalfampridine—KCND3—brainstem—malignant glioma	0.00369	0.00541	CbGeAlD
Dalfampridine—KCNV2—brain—malignant glioma	0.00366	0.00537	CbGeAlD
Dalfampridine—KCNC3—cerebellum—malignant glioma	0.00361	0.00529	CbGeAlD
Dalfampridine—KCNA4—central nervous system—malignant glioma	0.00359	0.00526	CbGeAlD
Dalfampridine—KCNA3—central nervous system—malignant glioma	0.00359	0.00526	CbGeAlD
Dalfampridine—KCNA1—retina—malignant glioma	0.00358	0.00524	CbGeAlD
Dalfampridine—KCNF1—midbrain—malignant glioma	0.00353	0.00518	CbGeAlD
Dalfampridine—KCNA4—cerebellum—malignant glioma	0.00351	0.00514	CbGeAlD
Dalfampridine—KCNA3—cerebellum—malignant glioma	0.00351	0.00514	CbGeAlD
Dalfampridine—KCNG3—brain—malignant glioma	0.0035	0.00512	CbGeAlD
Dalfampridine—KCNC2—brain—malignant glioma	0.0035	0.00512	CbGeAlD
Dalfampridine—KCNH1—brain—malignant glioma	0.0035	0.00512	CbGeAlD
Dalfampridine—KCNA5—medulla oblongata—malignant glioma	0.00346	0.00507	CbGeAlD
Dalfampridine—KCNF1—spinal cord—malignant glioma	0.00345	0.00505	CbGeAlD
Dalfampridine—KCNS1—central nervous system—malignant glioma	0.00341	0.005	CbGeAlD
Dalfampridine—KCNA2—central nervous system—malignant glioma	0.00341	0.005	CbGeAlD
Dalfampridine—KCNS3—medulla oblongata—malignant glioma	0.00339	0.00496	CbGeAlD
Dalfampridine—KCNQ3—medulla oblongata—malignant glioma	0.00339	0.00496	CbGeAlD
Dalfampridine—KCNA2—cerebellum—malignant glioma	0.00334	0.00489	CbGeAlD
Dalfampridine—KCNA1—telencephalon—malignant glioma	0.00329	0.00482	CbGeAlD
Dalfampridine—KCND3—telencephalon—malignant glioma	0.00327	0.0048	CbGeAlD
Dalfampridine—KCNC4—central nervous system—malignant glioma	0.00327	0.00479	CbGeAlD
Dalfampridine—KCND1—central nervous system—malignant glioma	0.00327	0.00479	CbGeAlD
Dalfampridine—KCND1—cerebellum—malignant glioma	0.00319	0.00468	CbGeAlD
Dalfampridine—KCNC4—cerebellum—malignant glioma	0.00319	0.00468	CbGeAlD
Dalfampridine—KCNH7—central nervous system—malignant glioma	0.00314	0.0046	CbGeAlD
Dalfampridine—KCNC1—central nervous system—malignant glioma	0.00314	0.0046	CbGeAlD
Dalfampridine—KCNG1—brain—malignant glioma	0.00312	0.00457	CbGeAlD
Dalfampridine—KCNH3—brain—malignant glioma	0.00312	0.00457	CbGeAlD
Dalfampridine—KCNS3—midbrain—malignant glioma	0.00309	0.00454	CbGeAlD
Dalfampridine—KCNQ3—midbrain—malignant glioma	0.00309	0.00454	CbGeAlD
Dalfampridine—KCNA5—spinal cord—malignant glioma	0.00308	0.00452	CbGeAlD
Dalfampridine—KCNH7—cerebellum—malignant glioma	0.00307	0.00449	CbGeAlD
Dalfampridine—KCNC1—cerebellum—malignant glioma	0.00307	0.00449	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—malignant glioma	0.00307	0.00449	CbGeAlD
Dalfampridine—KCNQ5—central nervous system—malignant glioma	0.00305	0.00447	CbGeAlD
Dalfampridine—KCNS3—spinal cord—malignant glioma	0.00302	0.00443	CbGeAlD
Dalfampridine—KCNH8—brain—malignant glioma	0.00302	0.00442	CbGeAlD
Dalfampridine—KCNB1—brain—malignant glioma	0.00302	0.00442	CbGeAlD
Dalfampridine—KCND2—medulla oblongata—malignant glioma	0.00295	0.00433	CbGeAlD
Dalfampridine—KCNC3—brain—malignant glioma	0.00293	0.00429	CbGeAlD
Dalfampridine—KCNA4—brain—malignant glioma	0.00285	0.00418	CbGeAlD
Dalfampridine—KCNA3—brain—malignant glioma	0.00285	0.00418	CbGeAlD
Dalfampridine—KCNF1—central nervous system—malignant glioma	0.0028	0.0041	CbGeAlD
Dalfampridine—KCNF1—cerebellum—malignant glioma	0.00273	0.00401	CbGeAlD
Dalfampridine—KCNA2—brain—malignant glioma	0.00271	0.00397	CbGeAlD
Dalfampridine—KCNS1—brain—malignant glioma	0.00271	0.00397	CbGeAlD
Dalfampridine—KCND2—midbrain—malignant glioma	0.0027	0.00395	CbGeAlD
Dalfampridine—KCND2—spinal cord—malignant glioma	0.00263	0.00386	CbGeAlD
Dalfampridine—KCNC4—brain—malignant glioma	0.00259	0.0038	CbGeAlD
Dalfampridine—KCND1—brain—malignant glioma	0.00259	0.0038	CbGeAlD
Dalfampridine—KCNA5—central nervous system—malignant glioma	0.0025	0.00367	CbGeAlD
Dalfampridine—KCNQ1—medulla oblongata—malignant glioma	0.00249	0.00365	CbGeAlD
Dalfampridine—KCNH7—brain—malignant glioma	0.00249	0.00365	CbGeAlD
Dalfampridine—KCNQ4—brain—malignant glioma	0.00249	0.00365	CbGeAlD
Dalfampridine—KCNC1—brain—malignant glioma	0.00249	0.00365	CbGeAlD
Dalfampridine—KCNQ3—central nervous system—malignant glioma	0.00245	0.00359	CbGeAlD
Dalfampridine—KCNQ5—brain—malignant glioma	0.00242	0.00355	CbGeAlD
Dalfampridine—KCNQ3—cerebellum—malignant glioma	0.00239	0.00351	CbGeAlD
Dalfampridine—KCNA1—midbrain—malignant glioma	0.00236	0.00346	CbGeAlD
Dalfampridine—KCND3—midbrain—malignant glioma	0.00235	0.00345	CbGeAlD
Dalfampridine—KCNA1—spinal cord—malignant glioma	0.00231	0.00338	CbGeAlD
Dalfampridine—KCNQ2—central nervous system—malignant glioma	0.00225	0.0033	CbGeAlD
Dalfampridine—KCNH6—central nervous system—malignant glioma	0.00224	0.00328	CbGeAlD
Dalfampridine—KCNF1—brain—malignant glioma	0.00222	0.00325	CbGeAlD
Dalfampridine—KCNQ2—cerebellum—malignant glioma	0.0022	0.00323	CbGeAlD
Dalfampridine—KCND2—central nervous system—malignant glioma	0.00213	0.00313	CbGeAlD
Dalfampridine—KCND2—cerebellum—malignant glioma	0.00209	0.00306	CbGeAlD
Dalfampridine—KCNA5—brain—malignant glioma	0.00199	0.00291	CbGeAlD
Dalfampridine—KCNS3—brain—malignant glioma	0.00194	0.00285	CbGeAlD
Dalfampridine—KCNQ3—brain—malignant glioma	0.00194	0.00285	CbGeAlD
Dalfampridine—KCNA1—central nervous system—malignant glioma	0.00187	0.00274	CbGeAlD
Dalfampridine—KCND3—central nervous system—malignant glioma	0.00186	0.00273	CbGeAlD
Dalfampridine—Urinary tract infection—Carmustine—malignant glioma	0.00186	0.0269	CcSEcCtD
Dalfampridine—Infestation—Temozolomide—malignant glioma	0.00185	0.0268	CcSEcCtD
Dalfampridine—Infestation NOS—Temozolomide—malignant glioma	0.00185	0.0268	CcSEcCtD
Dalfampridine—KCNA1—cerebellum—malignant glioma	0.00183	0.00268	CbGeAlD
Dalfampridine—KCND3—cerebellum—malignant glioma	0.00182	0.00267	CbGeAlD
Dalfampridine—Urinary tract infection—Temozolomide—malignant glioma	0.0018	0.026	CcSEcCtD
Dalfampridine—KCNQ2—brain—malignant glioma	0.00179	0.00262	CbGeAlD
Dalfampridine—KCNH6—brain—malignant glioma	0.00177	0.0026	CbGeAlD
Dalfampridine—KCND2—brain—malignant glioma	0.00169	0.00248	CbGeAlD
Dalfampridine—Connective tissue disorder—Carmustine—malignant glioma	0.00169	0.0244	CcSEcCtD
Dalfampridine—Connective tissue disorder—Temozolomide—malignant glioma	0.00163	0.0236	CcSEcCtD
Dalfampridine—Angiopathy—Temozolomide—malignant glioma	0.0015	0.0218	CcSEcCtD
Dalfampridine—Mental disorder—Carmustine—malignant glioma	0.0015	0.0218	CcSEcCtD
Dalfampridine—Immune system disorder—Temozolomide—malignant glioma	0.0015	0.0217	CcSEcCtD
Dalfampridine—Mediastinal disorder—Temozolomide—malignant glioma	0.00149	0.0216	CcSEcCtD
Dalfampridine—KCNA1—brain—malignant glioma	0.00149	0.00218	CbGeAlD
Dalfampridine—KCND3—brain—malignant glioma	0.00148	0.00217	CbGeAlD
Dalfampridine—Mental disorder—Temozolomide—malignant glioma	0.00145	0.021	CcSEcCtD
Dalfampridine—Back pain—Carmustine—malignant glioma	0.00145	0.0209	CcSEcCtD
Dalfampridine—KCNQ1—brain—malignant glioma	0.00143	0.0021	CbGeAlD
Dalfampridine—Tremor—Carmustine—malignant glioma	0.0014	0.0203	CcSEcCtD
Dalfampridine—Back pain—Temozolomide—malignant glioma	0.0014	0.0202	CcSEcCtD
Dalfampridine—Tremor—Temozolomide—malignant glioma	0.00135	0.0196	CcSEcCtD
Dalfampridine—Angioedema—Temozolomide—malignant glioma	0.00132	0.0191	CcSEcCtD
Dalfampridine—Convulsion—Carmustine—malignant glioma	0.00129	0.0187	CcSEcCtD
Dalfampridine—Chest pain—Carmustine—malignant glioma	0.00127	0.0184	CcSEcCtD
Dalfampridine—Anxiety—Carmustine—malignant glioma	0.00127	0.0184	CcSEcCtD
Dalfampridine—Convulsion—Temozolomide—malignant glioma	0.00125	0.0181	CcSEcCtD
Dalfampridine—Confusional state—Carmustine—malignant glioma	0.00123	0.0178	CcSEcCtD
Dalfampridine—Anxiety—Temozolomide—malignant glioma	0.00122	0.0177	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00122	0.0177	CcSEcCtD
Dalfampridine—Infection—Carmustine—malignant glioma	0.00121	0.0175	CcSEcCtD
Dalfampridine—KCNH2—telencephalon—malignant glioma	0.00121	0.00177	CbGeAlD
Dalfampridine—Confusional state—Temozolomide—malignant glioma	0.00119	0.0172	CcSEcCtD
Dalfampridine—Anaphylactic shock—Temozolomide—malignant glioma	0.00118	0.0171	CcSEcCtD
Dalfampridine—Infection—Temozolomide—malignant glioma	0.00117	0.017	CcSEcCtD
Dalfampridine—Nervous system disorder—Temozolomide—malignant glioma	0.00116	0.0167	CcSEcCtD
Dalfampridine—Skin disorder—Temozolomide—malignant glioma	0.00114	0.0166	CcSEcCtD
Dalfampridine—Hypotension—Carmustine—malignant glioma	0.00114	0.0165	CcSEcCtD
Dalfampridine—Insomnia—Carmustine—malignant glioma	0.0011	0.016	CcSEcCtD
Dalfampridine—Paraesthesia—Carmustine—malignant glioma	0.00109	0.0159	CcSEcCtD
Dalfampridine—Dyspnoea—Carmustine—malignant glioma	0.00109	0.0157	CcSEcCtD
Dalfampridine—Insomnia—Temozolomide—malignant glioma	0.00107	0.0154	CcSEcCtD
Dalfampridine—Paraesthesia—Temozolomide—malignant glioma	0.00106	0.0153	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00105	0.0152	CcSEcCtD
Dalfampridine—Dyspnoea—Temozolomide—malignant glioma	0.00105	0.0152	CcSEcCtD
Dalfampridine—Constipation—Carmustine—malignant glioma	0.00104	0.0151	CcSEcCtD
Dalfampridine—Dyspepsia—Temozolomide—malignant glioma	0.00104	0.015	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00102	0.0147	CcSEcCtD
Dalfampridine—Constipation—Temozolomide—malignant glioma	0.00101	0.0146	CcSEcCtD
Dalfampridine—Feeling abnormal—Carmustine—malignant glioma	0.001	0.0146	CcSEcCtD
Dalfampridine—Feeling abnormal—Temozolomide—malignant glioma	0.000971	0.0141	CcSEcCtD
Dalfampridine—KCNH2—medulla oblongata—malignant glioma	0.00095	0.00139	CbGeAlD
Dalfampridine—Urticaria—Temozolomide—malignant glioma	0.000936	0.0136	CcSEcCtD
Dalfampridine—CYP2E1—telencephalon—malignant glioma	0.000931	0.00136	CbGeAlD
Dalfampridine—Hypersensitivity—Carmustine—malignant glioma	0.000898	0.013	CcSEcCtD
Dalfampridine—Asthenia—Carmustine—malignant glioma	0.000875	0.0127	CcSEcCtD
Dalfampridine—Hypersensitivity—Temozolomide—malignant glioma	0.000868	0.0126	CcSEcCtD
Dalfampridine—KCNH2—midbrain—malignant glioma	0.000868	0.00127	CbGeAlD
Dalfampridine—KCNH2—spinal cord—malignant glioma	0.000847	0.00124	CbGeAlD
Dalfampridine—Asthenia—Temozolomide—malignant glioma	0.000845	0.0122	CcSEcCtD
Dalfampridine—Dizziness—Carmustine—malignant glioma	0.000806	0.0117	CcSEcCtD
Dalfampridine—Dizziness—Temozolomide—malignant glioma	0.000779	0.0113	CcSEcCtD
Dalfampridine—Vomiting—Carmustine—malignant glioma	0.000775	0.0112	CcSEcCtD
Dalfampridine—Rash—Carmustine—malignant glioma	0.000769	0.0111	CcSEcCtD
Dalfampridine—Dermatitis—Carmustine—malignant glioma	0.000768	0.0111	CcSEcCtD
Dalfampridine—Headache—Carmustine—malignant glioma	0.000764	0.0111	CcSEcCtD
Dalfampridine—Vomiting—Temozolomide—malignant glioma	0.000749	0.0108	CcSEcCtD
Dalfampridine—Rash—Temozolomide—malignant glioma	0.000743	0.0108	CcSEcCtD
Dalfampridine—Dermatitis—Temozolomide—malignant glioma	0.000742	0.0107	CcSEcCtD
Dalfampridine—Headache—Temozolomide—malignant glioma	0.000738	0.0107	CcSEcCtD
Dalfampridine—CYP2E1—medulla oblongata—malignant glioma	0.000731	0.00107	CbGeAlD
Dalfampridine—Nausea—Carmustine—malignant glioma	0.000724	0.0105	CcSEcCtD
Dalfampridine—Nausea—Temozolomide—malignant glioma	0.0007	0.0101	CcSEcCtD
Dalfampridine—KCNH2—central nervous system—malignant glioma	0.000687	0.00101	CbGeAlD
Dalfampridine—KCNH2—cerebellum—malignant glioma	0.000671	0.000984	CbGeAlD
Dalfampridine—CYP2E1—spinal cord—malignant glioma	0.000652	0.000956	CbGeAlD
Dalfampridine—KCNH2—brain—malignant glioma	0.000545	0.000799	CbGeAlD
Dalfampridine—CYP2E1—central nervous system—malignant glioma	0.000529	0.000776	CbGeAlD
Dalfampridine—CYP2E1—cerebellum—malignant glioma	0.000517	0.000758	CbGeAlD
Dalfampridine—KCNB1—Metabolism—BCAN—malignant glioma	0.000423	0.0017	CbGpPWpGaD
Dalfampridine—CYP2E1—brain—malignant glioma	0.00042	0.000616	CbGeAlD
Dalfampridine—KCNG2—Neuronal System—BRAF—malignant glioma	0.000419	0.00168	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—BRAF—malignant glioma	0.000419	0.00168	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—BRAF—malignant glioma	0.000419	0.00168	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—MDM2—malignant glioma	0.000419	0.00168	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—MDM2—malignant glioma	0.000419	0.00168	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—RAF1—malignant glioma	0.000417	0.00168	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—RAF1—malignant glioma	0.000417	0.00168	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—BRAF—malignant glioma	0.000407	0.00164	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—BRAF—malignant glioma	0.000397	0.0016	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CAT—malignant glioma	0.00039	0.00157	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000368	0.00148	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—BRAF—malignant glioma	0.000363	0.00146	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—BRAF—malignant glioma	0.000363	0.00146	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—malignant glioma	0.000363	0.00146	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—malignant glioma	0.000363	0.00146	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—malignant glioma	0.000361	0.00145	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—IDH2—malignant glioma	0.00036	0.00145	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—IDH2—malignant glioma	0.00036	0.00145	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—IDH2—malignant glioma	0.00036	0.00145	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—BRAF—malignant glioma	0.000356	0.00143	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000356	0.00143	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000354	0.00142	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PTK2—malignant glioma	0.000351	0.00141	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PTK2—malignant glioma	0.000351	0.00141	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MDM2—malignant glioma	0.000351	0.00141	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MDM2—malignant glioma	0.000351	0.00141	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MDM2—malignant glioma	0.000351	0.00141	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—RAF1—malignant glioma	0.00035	0.00141	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—RAF1—malignant glioma	0.00035	0.00141	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—RAF1—malignant glioma	0.00035	0.00141	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MDM2—malignant glioma	0.000341	0.00137	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—IDH2—malignant glioma	0.000341	0.00137	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—RAF1—malignant glioma	0.00034	0.00137	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2B6—malignant glioma	0.000338	0.00136	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2B6—malignant glioma	0.000338	0.00136	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2B6—malignant glioma	0.000338	0.00136	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000337	0.00135	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MDM2—malignant glioma	0.000333	0.00134	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PTEN—malignant glioma	0.000333	0.00134	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—RAF1—malignant glioma	0.000332	0.00133	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—BRAF—malignant glioma	0.000322	0.00129	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2B6—malignant glioma	0.000321	0.00129	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—BRAF—malignant glioma	0.000317	0.00128	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000315	0.00127	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—IDH1—malignant glioma	0.000309	0.00124	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—IDH1—malignant glioma	0.000309	0.00124	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—IDH1—malignant glioma	0.000309	0.00124	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000308	0.00124	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MDM2—malignant glioma	0.000304	0.00122	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MDM2—malignant glioma	0.000304	0.00122	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—RAF1—malignant glioma	0.000303	0.00122	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—RAF1—malignant glioma	0.000303	0.00122	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SPHK1—malignant glioma	0.000299	0.0012	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SPHK1—malignant glioma	0.000299	0.0012	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SPHK1—malignant glioma	0.000299	0.0012	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MDM2—malignant glioma	0.000298	0.0012	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—RAF1—malignant glioma	0.000297	0.0012	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—FGFR1—malignant glioma	0.000294	0.00118	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—FGFR1—malignant glioma	0.000294	0.00118	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—IDH1—malignant glioma	0.000293	0.00118	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2C18—malignant glioma	0.000293	0.00118	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2C18—malignant glioma	0.000293	0.00118	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2C18—malignant glioma	0.000293	0.00118	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PTEN—malignant glioma	0.000291	0.00117	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2B6—malignant glioma	0.000287	0.00116	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SPHK1—malignant glioma	0.000284	0.00114	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000284	0.00114	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2C18—malignant glioma	0.000278	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KDR—malignant glioma	0.000277	0.00111	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KDR—malignant glioma	0.000277	0.00111	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MET—malignant glioma	0.000271	0.00109	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—malignant glioma	0.000271	0.00109	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—BRAF—malignant glioma	0.00027	0.00109	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BRAF—malignant glioma	0.00027	0.00109	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MDM2—malignant glioma	0.00027	0.00108	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—RAF1—malignant glioma	0.000269	0.00108	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MDM2—malignant glioma	0.000266	0.00107	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—RAF1—malignant glioma	0.000265	0.00107	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BCHE—malignant glioma	0.000263	0.00106	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000258	0.00104	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PTK2—malignant glioma	0.000251	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PTK2—malignant glioma	0.000251	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PTPN11—malignant glioma	0.00025	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PTPN11—malignant glioma	0.00025	0.00101	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2C18—malignant glioma	0.000249	0.001	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC6A3—malignant glioma	0.000248	0.000996	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HES1—malignant glioma	0.000246	0.00099	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HES1—malignant glioma	0.000246	0.00099	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000246	0.000988	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NCOR1—malignant glioma	0.000245	0.000984	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NCOR1—malignant glioma	0.000245	0.000984	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTT1—malignant glioma	0.000237	0.000954	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTT1—malignant glioma	0.000237	0.000954	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTT1—malignant glioma	0.000237	0.000954	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—malignant glioma	0.000227	0.000912	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MDM2—malignant glioma	0.000226	0.000909	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MDM2—malignant glioma	0.000226	0.000909	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—malignant glioma	0.000226	0.000908	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—malignant glioma	0.000226	0.000908	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—RAF1—malignant glioma	0.000225	0.000906	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—RAF1—malignant glioma	0.000225	0.000906	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—malignant glioma	0.000225	0.000904	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS1—malignant glioma	0.000222	0.000894	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS1—malignant glioma	0.000222	0.000894	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS1—malignant glioma	0.000222	0.000894	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—MDM2—malignant glioma	0.000216	0.000867	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS1—malignant glioma	0.000211	0.000847	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGFR1—malignant glioma	0.00021	0.000842	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGFR1—malignant glioma	0.00021	0.000842	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BCHE—malignant glioma	0.000207	0.000831	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BCHE—malignant glioma	0.000207	0.000831	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BCHE—malignant glioma	0.000207	0.000831	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC5A5—malignant glioma	0.000204	0.000821	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC5A5—malignant glioma	0.000204	0.000821	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC5A5—malignant glioma	0.000204	0.000821	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—malignant glioma	0.000202	0.00081	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—RAF1—malignant glioma	0.0002	0.000804	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RAF1—malignant glioma	0.0002	0.000804	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—malignant glioma	0.000198	0.000798	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—malignant glioma	0.000198	0.000795	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—malignant glioma	0.000198	0.000795	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—malignant glioma	0.000197	0.000793	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—malignant glioma	0.000197	0.000793	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BCHE—malignant glioma	0.000196	0.000788	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC5A5—malignant glioma	0.000194	0.000778	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—malignant glioma	0.000193	0.000776	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—malignant glioma	0.000193	0.000776	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—PTGS1—malignant glioma	0.000189	0.000759	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NOTCH1—malignant glioma	0.000186	0.000747	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NOTCH1—malignant glioma	0.000186	0.000747	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PTPN11—malignant glioma	0.000179	0.000718	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PTPN11—malignant glioma	0.000179	0.000718	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—malignant glioma	0.000175	0.000705	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—malignant glioma	0.000175	0.000705	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—malignant glioma	0.00017	0.000682	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—malignant glioma	0.00017	0.000682	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000168	0.000674	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT2—malignant glioma	0.000166	0.000669	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT2—malignant glioma	0.000166	0.000669	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—malignant glioma	0.000164	0.000661	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—malignant glioma	0.000164	0.000661	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—malignant glioma	0.000164	0.000661	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—malignant glioma	0.000161	0.000648	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—malignant glioma	0.000161	0.000648	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000161	0.000647	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00016	0.000645	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAT—malignant glioma	0.00016	0.000643	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAT—malignant glioma	0.00016	0.000643	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAT—malignant glioma	0.00016	0.000643	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—malignant glioma	0.000156	0.000627	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGF2—malignant glioma	0.000153	0.000615	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGF2—malignant glioma	0.000153	0.000615	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—malignant glioma	0.000152	0.000613	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—malignant glioma	0.000152	0.000613	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAT—malignant glioma	0.000152	0.00061	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NCOR1—malignant glioma	0.000151	0.000608	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NCOR1—malignant glioma	0.000151	0.000608	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NCOR1—malignant glioma	0.000151	0.000608	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NCOR1—malignant glioma	0.000143	0.000576	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAF1—malignant glioma	0.000143	0.000574	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAF1—malignant glioma	0.000143	0.000574	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RTEL1—malignant glioma	0.000141	0.000568	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—malignant glioma	0.000141	0.000568	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—malignant glioma	0.000141	0.000568	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—malignant glioma	0.00014	0.000562	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—malignant glioma	0.000138	0.000554	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—malignant glioma	0.000137	0.000551	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—malignant glioma	0.000137	0.000551	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000136	0.000547	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—malignant glioma	0.000134	0.00054	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—malignant glioma	0.00013	0.000521	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—malignant glioma	0.00013	0.000521	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—malignant glioma	0.000123	0.000495	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—malignant glioma	0.000123	0.000495	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—malignant glioma	0.000123	0.000495	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—malignant glioma	0.000121	0.000487	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—malignant glioma	0.000121	0.000487	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—malignant glioma	0.000117	0.00047	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000117	0.000469	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—malignant glioma	0.000113	0.000453	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—RAF1—malignant glioma	0.000112	0.000451	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—malignant glioma	0.000112	0.000451	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—malignant glioma	0.000112	0.000451	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—malignant glioma	0.000112	0.000451	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—malignant glioma	0.000109	0.000437	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—malignant glioma	0.000109	0.000437	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—malignant glioma	0.000108	0.000435	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—malignant glioma	0.000108	0.000435	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—malignant glioma	0.000108	0.000435	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—malignant glioma	0.000108	0.000433	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—malignant glioma	0.000108	0.000433	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—malignant glioma	0.000106	0.000428	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—malignant glioma	0.000103	0.000413	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—malignant glioma	9.87e-05	0.000397	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—malignant glioma	9.87e-05	0.000397	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—malignant glioma	9.87e-05	0.000397	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—malignant glioma	9.79e-05	0.000393	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—malignant glioma	9.79e-05	0.000393	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—malignant glioma	9.35e-05	0.000376	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—malignant glioma	9.32e-05	0.000375	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—malignant glioma	9.32e-05	0.000375	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—malignant glioma	9.24e-05	0.000372	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—malignant glioma	9.24e-05	0.000372	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—malignant glioma	8.6e-05	0.000346	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—malignant glioma	8.6e-05	0.000346	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—malignant glioma	8.6e-05	0.000346	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—malignant glioma	8.52e-05	0.000343	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—malignant glioma	8.52e-05	0.000343	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—malignant glioma	8.52e-05	0.000343	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—malignant glioma	8.15e-05	0.000328	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COX8A—malignant glioma	8.11e-05	0.000326	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—malignant glioma	8.08e-05	0.000325	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—malignant glioma	7.43e-05	0.000299	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—malignant glioma	7.43e-05	0.000299	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—malignant glioma	7.43e-05	0.000299	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—malignant glioma	7.04e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—malignant glioma	6.94e-05	0.000279	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—malignant glioma	6.94e-05	0.000279	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ASMT—malignant glioma	6.9e-05	0.000277	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCAN—malignant glioma	6.49e-05	0.000261	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—malignant glioma	5.24e-05	0.000211	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—malignant glioma	5.24e-05	0.000211	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—malignant glioma	5.24e-05	0.000211	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—IDH2—malignant glioma	5.23e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—malignant glioma	4.97e-05	0.0002	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2B6—malignant glioma	4.92e-05	0.000198	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—IDH1—malignant glioma	4.5e-05	0.000181	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SPHK1—malignant glioma	4.35e-05	0.000175	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—malignant glioma	4.28e-05	0.000172	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—malignant glioma	4.28e-05	0.000172	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—malignant glioma	4.28e-05	0.000172	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2C18—malignant glioma	4.26e-05	0.000171	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—malignant glioma	4.06e-05	0.000163	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—malignant glioma	3.45e-05	0.000139	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS1—malignant glioma	3.23e-05	0.00013	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—malignant glioma	3e-05	0.000121	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—malignant glioma	2.97e-05	0.000119	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—malignant glioma	2.39e-05	9.61e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAT—malignant glioma	2.33e-05	9.35e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOR1—malignant glioma	2.2e-05	8.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—malignant glioma	1.79e-05	7.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—malignant glioma	1.63e-05	6.55e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—malignant glioma	1.57e-05	6.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—malignant glioma	1.43e-05	5.76e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.25e-05	5.02e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—malignant glioma	1.24e-05	4.98e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—malignant glioma	1.08e-05	4.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—malignant glioma	7.62e-06	3.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—malignant glioma	6.22e-06	2.5e-05	CbGpPWpGaD
